Vorasidenib + Cyp3a Inducers Interaction

Majorinteraction on record

Description

Concomitant use may decrease vorasidenib plasma concentrations and reduce anti-tumor activity.

Mechanism

CYP1A2 induction

Source: NLP:vorasidenib